Grants for County governments - Health

Propeller’s Impact Accelerator is a 5-month program designed to support mission-driven entrepreneurs in growing their businesses through coaching, community building, curriculum, and technical assistance. The program aims to catalyze transformational growth by connecting entrepreneurs with contract opportunities, markets, and customers. It is sponsored by the Clif Family Foundation, Capital One, Nasdaq, RosaMary Foundation, WK Kellogg Foundation, and Baptist Community Ministries, aligning with their missions to foster economic development, education, and community well-being by empowering local businesses. The Impact Accelerator targets growth-stage entrepreneurs in five key areas: community economic development, education, food, health, and water. Specifically, it supports BIPOC entrepreneurs operating brick-and-mortar establishments in underserved New Orleans corridors for economic development; early childhood education and care providers for education; CPG brands emphasizing sustainable, healthy, and affordable products for food; direct health and wellness service providers, especially those serving BIPOC clients, for health; and entrepreneurs in green infrastructure, stormwater management, native plant cultivation, and coastal restoration for water. The program's overarching impact goal is to facilitate the scaling of revenues and teams, while also embedding racial equity, social, and environmental impact goals into business operations. The program's priorities and focuses are clearly delineated within each sector. For community economic development, the focus is on Black-owned brick-and-mortar storefronts in specific New Orleans neighborhoods, aiming for job creation and community ties. In education, the priority is on increasing enrollment, growing staff, and expanding business locations for early childhood education providers. For food, the emphasis is on CPG brands that are environmentally sound, locally sourced, healthy, or have compelling social/environmental impacts, with a prioritization of BIPOC-led companies. Health focuses on direct clinical care and services impacting social and physical determinants of health, especially for BIPOC client bases, striving for increased accessibility and staff growth. The water sector prioritizes green infrastructure, urban stormwater management, native plants, and coastal restoration, seeking to increase the supply of native plants for green infrastructure. Expected outcomes and measurable results include participants setting ambitious yet achievable goals for growth and long-term sustainability, an increase in business revenues and staff, and the successful attainment of social/environmental impact goals. Entrepreneurs receive over 16 hours of lead mentor office hours for goal setting, 12+ hours of business development curriculum during meetups, and 20+ hours with subject matter experts for project assistance. Additional benefits include a detailed work plan, coaching on racial equity and impact goals, introductions to stakeholders, free coworking space, and membership in a network of over 250 alumni. These structured interventions are designed to remove growth barriers and accelerate the development of entrepreneurial ventures, leading to tangible economic and social improvements within the targeted communities and sectors.

This funding opportunity provides financial support to organizations working to improve HIV prevention and treatment for Haitian migrants and their descendants in the Dominican Republic, focusing on overcoming barriers to healthcare access and enhancing treatment outcomes.

This grant provides funding to Colorado artists, activists, and organizations to implement projects that use the arts to promote social justice and improve community welfare.

The Arts in Society Grant, funded by the Colorado Office of Economic Development and International Trade (OEDIT), aims to leverage the arts to address civic and social challenges within Colorado communities. This program aligns with a broader mission of fostering community development and social justice through creative engagement, recognizing the arts as a powerful tool for societal change and problem-solving. The grant offers both financial and organizational support, indicating a commitment to not only fund projects but also to nurture the growth and impact of participating artists and organizations. The target beneficiaries for this grant are broad, encompassing Colorado artists, activists, nonprofit organizations, universities and schools, government agencies, human service groups, neighborhood organizations, and healthcare organizations. The program particularly encourages applications from individual artists and non-arts organizations, emphasizing inclusivity and a cross-sector approach. The impact goals are centered on empowering these diverse groups to collaborate on projects where artists, organizations, and a target community work together to address specific social issues, ultimately leading to positive community transformation. The program's priorities and focuses include fostering collaboration, building support networks, and illustrating the impact of arts in cross-sector projects. Grantees are expected to attend learning community meetings to build support and share resources, underscoring a strategic priority of community building and knowledge exchange among participants. Another key focus is the promotion of grantee work through various marketing channels, highlighting the program's commitment to showcasing successful initiatives and advocating for the value of arts in society. Expected outcomes and measurable results include the successful completion of projects within 24 months, with an emphasis on projects that demonstrably engage a social issue and involve collaborative efforts. The mini-documentary highlighting grantee work and participation in evaluation processes are crucial mechanisms for measuring and illustrating the impacts of the arts in these cross-sector endeavors. This suggests a strategic priority of OEDIT to document and disseminate the effectiveness of arts-based solutions to civic and social challenges, thereby validating and expanding the theory of change that art can be a catalyst for tangible societal improvement.

This grant provides funding to support career development and mentoring for junior faculty in clinical rehabilitation fields, helping them transition to independent research roles that improve the health and quality of life for individuals with chronic disabilities.

This funding opportunity provides financial support for researchers to quickly evaluate new policies or programs aimed at influencing behaviors related to obesity, such as diet and physical activity, to help prevent or reduce obesity rates.

This grant provides funding for researchers to investigate the genetic and environmental causes of structural birth defects, promoting collaboration between scientists and clinicians to improve prevention and treatment strategies.

The "Tuberculosis Elimination and Laboratory Cooperative Agreement" is a CDC grant aimed at supporting state, local, and territorial health programs in their efforts to prevent, control, and eliminate tuberculosis in the U.S. through diagnosis, treatment, surveillance, and laboratory support, particularly in high-risk populations and regions with high TB burdens.

This funding opportunity supports high-risk, multi-center observational studies aimed at advancing research on diabetes, digestive diseases, kidney disorders, and other related health conditions, encouraging diverse institutions to collaborate and innovate.

This Notice of Funding Opportunity (NOFO) invites U24 Cooperative Agreement applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials. The Network will serve as a centralized hub for developing, validating, standardizing, and disseminating measures and measurement methods for AD/ADRD primary prevention trials. It will incorporate measures and measurement methods across neuropsychological, biomarker, and functional domains to meet the goal of primary prevention of AD/ADRD centered around brain health equity.

This funding opportunity supports doctoral candidates conducting research on substance use and substance use disorders, helping them complete their dissertation projects while fostering new talent in the field.

This funding opportunity provides financial support to organizations in Illinois working to improve broadband access, digital literacy, and inclusion for underserved communities, helping bridge the digital divide and promote economic development.

This funding opportunity provides financial support for eligible organizations to research and analyze the incidence of epilepsy among children in the U.S., focusing on disparities and risk factors using advanced data science techniques.

The "Neuromodulation/Neurostimulation Device Development for Mental Health Applications" grant aims to fund the development of innovative brain stimulation devices or significant hardware/software enhancements to existing FDA-approved devices, with a focus on improving precision and delivery, for the treatment of mental health disorders.

This funding opportunity supports U.S. institutions and organizations in developing animal models and biological resources to advance research on Down syndrome and its related health conditions.

This funding opportunity provides support for the ongoing development and maintenance of valuable informatics tools and resources that enhance cancer research and management, benefiting researchers and the broader cancer community.

This grant provides financial support to urban farmers in Minnesota for implementing conservation practices that improve environmental health and farm sustainability.

The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. Section I. Funding Opportunity Description The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. NIH Institutes and Centers (ICs) support a variety of mentored and non-mentored career development award programs designed to foster the transition of new investigators to research independence and to support established investigators in achieving specific objectives. Candidates should review the different career development (K) award programs to determine the best program to support their goals. More information about Career programs may be found at the NIH Extramural Training Mechanisms website. The NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is designed to enable mid-career clinician-scientists to: Devote more time to augment their capabilities in Patient-Oriented Research (POR); and Provide mentoring to junior clinical investigators in the conduct of POR (see below for definition). The K24 award is intended to provide protected time to mid-career clinical investigators to provide mentoring to junior clinical investigators, particularly K23 grantees, in POR and to stabilize the careers of these investigators. The intent is to allow these investigators to continue to conduct POR and be available as mentors in POR. It is expected that K24 recipients will obtain new or additional independent, peer-reviewed funding for POR as PD/PI and establish and assume leadership roles in collaborative POR programs. In addition, it is expected that there will be an increased effort and commitment to act as a mentor to beginning clinician investigators in POR to enhance the research productivity of both the K24 investigator and increase the pool of well-trained clinical researchers of the future. For the purposes of the K24 award, Patient-Oriented Research is defined as research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This area of research includes: (1) mechanisms of human disease; (2) therapeutic interventions; (3) clinical trials, and; (4) the development of new technologies. Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, patient-oriented research is research in which it is necessary to know the identity of the patients from whom the cells or tissues under study are derived. Studies falling under Exemption 4 for human subjects research are not included in this definition. See also the NIH Director's Panel on Clinical Research Report. NIH defines a clinical trial as "A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes." (NOT-OD-15-015). NIH not only supports trials of safety and efficacy, it also supports mechanistic exploratory studies that meet the definition of a clinical trial and are designed to explore or understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention. These studies may focus on basic and/or translational discovery research in healthy human subjects and in human subjects who are affected by the pathophysiology of diseases and disorders. By addressing basic questions and concepts in biology, behavior, and pathophysiology, these studies may provide insight into understanding human diseases and disorders along with potential treatments or preventive strategies. NIH also supports biomarker studies that meet the definition of a clinical trial and that may provide information about physiological function, target engagement of novel therapeutics, and/or the impact of therapeutics on treatment response. NIH thus supports studies that meet the definition of clinical trials (as noted above) but do not seek to establish safety, clinical efficacy, effectiveness, clinical management, and/or implementation of preventive, therapeutic, and services interventions. Note: This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA Special Note: Because of the differences in individual Institute and Center (IC) program requirements for this FOA, prospective candidates are strongly encouraged to consult the Table of IC-Specific Information, Requirements and Staff Contacts, to make sure that their application is appropriate for the requirements of one of the participating NIH ICs. See Section VIII. Other Information for award authorities and regulations. Section II. Award Information Funding Instrument Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Application Types Allowed New Resubmission Revision Renewal The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA. Clinical Trial? Required: Only accepting applications that propose an independent clinical trial(s) Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Award Budget Award budgets are composed of salary and other program-related expenses, as described below. Award Project Period The total project period may not exceed 5 years.

This grant provides funding for research on behavioral sleep interventions aimed at improving sleep and mental health outcomes for adolescents and young adults, particularly those from underserved populations.

This grant provides funding to organizations and initiatives focused on improving access to newborn hearing screening and services in Minnesota.